Windtree Therapeutics Net Income

Windtree Therapeutics (WINT) currently reports a net income of $-46M as of September 2025. That compares with $-11M in the prior-year period — down 325.4% year over year. That is below the Healthcare sector average of $17B. Use the charts on this page to explore Windtree Therapeutics's net income history and peer comparisons.

Windtree Therapeutics's net income decreased from $-11M to $-46M — a 325.4% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Windtree Therapeutics's net income of $-46M is lower than the Healthcare sector average of $17B. That is roughly 100.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Windtree Therapeutics reported $-46M in net income as of September 2025. That compares with $-11M in the prior-year period — down 325.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-46M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $17B. From there, open related valuation or income-statement pages for Windtree Therapeutics, and consider following WINT for alerts when major investors trade the stock.